Related Experiment Video

Updated: May 18, 2026

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation
15:05

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation

Published on: May 20, 2020

Where EGF receptors transmit their signals

Nancy L Lill1, Nurettin Ilter Sever

  • 1Department of Pathology and the OSU Comprehensive Cancer Center, Ohio State University, Columbus, OH 43210, USA. nancy.lill@osumc.edu

Science Signaling
|September 27, 2012
PubMed

Insights

Targeting the earliest stages of epidermal growth factor receptor (EGFR) trafficking may effectively suppress cancer-promoting signals. This approach focuses on specific EGFR locations within the cell to optimize therapeutic strategies against receptor tyrosine kinase (RTK) driven cancers.

Area of Science:

  • Cell Biology
  • Molecular Oncology
  • Cancer Therapeutics

Background:

  • Receptor tyrosine kinases (RTKs), such as the epidermal growth factor receptor (EGFR), are crucial for cell signaling but can drive cancer when overactive.
  • Understanding the molecular mechanisms that regulate RTK signaling and their potential defects in tumors is essential for developing effective cancer therapies.
  • The trafficking pathway of EGFR influences its signaling amplitude and downstream effects.

Purpose of the Study:

  • To investigate the molecular mechanisms controlling epidermal growth factor receptor (EGFR) signaling.
  • To determine if these regulatory mechanisms are defective in cancer cells.
  • To explore the potential of targeting specific EGFR trafficking stages for cancer therapy.

Main Methods:

  • Mechanistic studies focusing on the epidermal growth factor receptor (EGFR) as a prototypical RTK.
  • Analysis of EGFR signaling and transcriptional responses at different stages of its degradative trafficking pathway (cell surface, endosomes, lysosomes).
  • Investigating the role of endosomal sorting complex required for transport (ESCRT) complexes in EGFR regulation.

Main Results:

  • EGFRs at the plasma membrane are responsible for the majority of the global transcriptional response to EGF.
  • EGFRs between internalization and early endosome fusion stages are associated with enriched expression of cancer-related transcripts.
  • EGFRs at later trafficking stages, regulated by ESCRT complexes, do not significantly contribute to the EGFR-mediated transcriptional response.

Conclusions:

  • The location of EGFR within the degradative trafficking pathway dictates its contribution to oncogenic signaling.
  • Targeting EGFRs at the earliest stages of their trafficking pathway, from the cell surface to early endosomes, may be the most effective therapeutic strategy.
  • Restoring normal regulatory pathways by targeting specific EGFR trafficking sites holds promise for cancer treatment.

More Related Videos

Tension Gauge Tether Probes for Quantifying Growth Factor Mediated Integrin Mechanics and Adhesion09:56

Tension Gauge Tether Probes for Quantifying Growth Factor Mediated Integrin Mechanics and Adhesion

Published on: February 11, 2022

A Functional Assay for Gap Junctional Examination; Electroporation of Adherent Cells on Indium-Tin Oxide11:02

A Functional Assay for Gap Junctional Examination; Electroporation of Adherent Cells on Indium-Tin Oxide

Published on: October 18, 2014

Related Concept Videos

Amplifying Signals via Second Messengers01:15

Amplifying Signals via Second Messengers

Many receptor binding ligands are hydrophilic; they do not cross the cell membrane but bind to cell-surface receptors. Thus, their message must be relayed by second messengers present in the cell cytoplasm. There are several second messenger pathways, each with its own way of relaying information. For example, the G protein-coupled receptors can activate both phosphoinositol and cyclic AMP (cAMP) second messenger pathways. The phosphoinositol pathway is active when the receptor induces...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include: